CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 94 enrolled
Drug / intervention
140kms cyclingother
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT03310450
NCT03310450N/ACompleted
CompareCT.gov

Predictors of Cardiac Troponin Release After Tour de Borobudur 2017

Universitas Negeri Semarang·observational·Posted Oct 16, 2017·Updated Oct 10, 2019

In Brief

An observational study evaluating 140kms cycling for Heart Arrest and 3 related conditions. Completed, enrolled 94 participants across 1 site.

Detailed Summary

Prospective observational study to determine predictors that related to cardiac troponin I (cTnI) release, malondialdehyde (MDA) and high sensitivity C Reactive Protein (hs-CRP) after Tour de Borobudur (TdB) 2017

Study Details

Study Typeobservational
Allocation--
Masking--
Primary Purpose--
ConditionsHeart Arrest, Sport Injury, Inflammatory Response, Oxidative Stress
CountriesIndonesia
CollaboratorsMinistry of Research, Technology and Higher Education, Republic of Indonesia, Universitas Diponegoro

Timeline

N/ACompletedFinished
201820192020202120222023202420252026
First PostedOct 16, 2017
Enrollment StartOct 28, 2017
Primary CompletionNov 11, 2017
Study CompletionMay 5, 2018
TodayJul 2, 2026
Enrollment to primary: 13 daysPosted 8.7 years ago

Interventions

140kms cyclingother

Main exposure is long distance cycling touring (TdB/NC) consists of three groups; 140kms, 100kms, and 240kms (investigator did not give any treatment/intervention, just observed the cycling touring event)